Moraxella (Branhamella) catarrhalis BRO β-lactamase:: a lipoprotein of gram-positive origin?

被引：27

作者：

Bootsma, HJ

Aerts, PC

Posthuma, G

Harmsen, T

Verhoef, J

van Dijk, H

Mooi, FR

机构：

[1] Univ Utrecht Hosp, Eijkman Winkler Inst Microbiol Infect Dis & Infla, NL-3508 GA Utrecht, Netherlands

[2] Univ Utrecht, Grad Sch Biomembranes, Utrecht, Netherlands

[3] Univ Utrecht, Dept Cell Biol, Utrecht, Netherlands

[4] Natl Inst Publ Hlth & Environm, Res Lab Infect Dis, NL-3720 BA Bilthoven, Netherlands

来源：

JOURNAL OF BACTERIOLOGY | 1999年 / 181卷 / 16期

关键词：

D O I：

10.1128/JB.181.16.5090-5093.1999

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

In the past 20 years, BRO P-lactamase-producing Moraxella catarrhalis strains have emerged. We show that BRO is expressed as a 33-kDa lipoprotein associated with the inner leaflet of the outer membrane. To our knowledge, this is the first description of a lipidated P-lactamase in a gram-negative species.

引用

收藏

页码：5090 / 5093

页数：4

相关论文

共 25 条

[1] Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis [J].

Bootsma, HJ ;

vanDijk, H ;

Verhoef, J ;

Fleer, A ;

Mooi, FR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) :966-972

[2] BRANHAMELLA (MORAXELLA) CATARRHALIS - PATHOGENIC SIGNIFICANCE IN RESPIRATORY-INFECTIONS [J].

BOYLE, FM ;

GEORGHIOU, PR ;

TILSE, MH ;

MCCORMACK, JG .

MEDICAL JOURNAL OF AUSTRALIA, 1991, 154 (09) :592-596

[3]

BRAUN V, 1994, N COMP BIOC, V27, P319, DOI DOI 10.1016/S0167-7306(08)60417-2

[4] BRANHAMELLA-CATARRHALIS - AN ORGANISM GAINING RESPECT AS A PATHOGEN [J].

CATLIN, BW .

CLINICAL MICROBIOLOGY REVIEWS, 1990, 3 (04) :293-320

[5] ELECTRON MICROSCOPY OF PLASMOLYSIS IN ESCHERICHIA COLI [J].

COTAROBLES, EH .

JOURNAL OF BACTERIOLOGY, 1963, 85 (03) :499-&

[6] Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: Results of a 30-center national surveillance study [J].

Doern, GV ;

Brueggemann, AB ;

Pierce, G ;

Hogan, T ;

Holley, HP ;

Rauch, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) :2884-2886

[7] CHARACTERIZATION OF CELL-BOUND PAPAIN-SOLUBLE BETA-LACTAMASES IN BRO-1 AND BRO-2 PRODUCING STRAINS OF MORAXELLA-(BRANHAMELLA)-CATARRHALIS AND MORAXELLA-NONLIQUEFACIENS [J].

ELIASSON, I ;

KAMME, C ;

VANG, M ;

WALEY, SG .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (04) :313-321

[8] NOVEL BETA-LACTAMASE FROM CAPNOCYTOPHAGA SP [J].

FOWERAKER, JE ;

HAWKEY, PM ;

HERITAGE, J ;

VANLANDUYT, HW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (08) :1501-1504

[9] SUSCEPTIBILITY OF MORAXELLA-CATARRHALIS ISOLATES TO BETA-LACTAM ANTIBIOTICS IN RELATION TO BETA-LACTAMASE PATTERN [J].

FUNG, CP ;

YEO, SF ;

LIVERMORE, DM .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (02) :215-222

[10]

HOL C, 1994, J INFECT DIS, V170, P1613